The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday. The findings could lead to new tests to determine ...
Read more...
CARY, N.C., Dec. 4 /PRNewswire/ -- College basketball analyst and sports ambassador Dick Vitale and co-host of ESPN's Pardon the Interruption Michael Wilbon have teamed up with ESPN, The V Foundation for Cancer Research(R) and Stand Up To Cancer(TM ...
Read more...
A new blood scanner developed by Stanford researchers may allow doctors to identify cancer in patients sooner, and treat the disease faster, say researchers. It can search for cancer-associated proteins in a blood sample and returns results in less ...
Read more...
No comments posted. Robert M. Jelenic, 58, former chairman and chief executive officer of Journal Register Co., publisher of the Daily Freeman, died Wednesday night in Pennsylvania after a long bout with cancer. Jelenic, 58, was the architect and ...
Read more...
NEW YORK & NEWPORT, R.I.--(BUSINESS WIRE)--Dec 4, 2008 - ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) and the Hope Funds for Cancer Research announced today that Jonathan Lewis, MD, PhD, Chief Executive and Medical Officer of ZIOPHARM, has been appointed ...
Read more...
Brazzaville — At least 70 percent of patients diagnosed with cancer in the Republic of Congo die within 12 months of screening because treatment facilities are expensive and inadequate, health specialists said. The patients die, according to Judith ...
Read more...
The university hospital in Brazzaville is the only facility offering cancer screening and treatment services in the Congo BRAZZAVILLE, 4 December 2008 (IRIN) - At least 70 percent of patients diagnosed with cancer in the Republic of Congo die within ...
Read more...
MONTPELLIER , France , Dec. 4 /PRNewswire-FirstCall/ -- A 60-year-old prostate cancer patient from Montpellier has become the first person in France to be treated using RapidArc(TM) technology from Varian Medical Systems (NYSE: VAR) for fast and ...
Read more...
After studying the biochemical makeup of the protein and identifying the gene that controlled its function, they began to search gene-sequencing databases worldwide to find what it was. They didn't find the enzyme listed for blood, but got a match ...
Read more...
MADRID, Dec 4 (Reuters) - Spanish pharmaceutical company Zeltia (ZEL.MC: Quote , Profile , Research , Stock Buzz ) said on Thursday it has submitted an application to the European Medicines Agency to approve its Yondelis drug for the treatment of ...
Read more...